TOLVAPTAN
Generic: TOLVAPTAN
Camber PharmaceuticalsManufacturer
ORALRoute
TOLVAPTANActive Substance
2022-09-06Original Approval
TOLVAPTAN is FDA application ANDA205646, sponsored by HETERO LABS LTD V. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
THIRST
821 reports
2
PRODUCT DOSE OMISSION ISSUE
693 reports
3
DEATH
561 reports
4
POLLAKIURIA
509 reports
5
RENAL IMPAIRMENT
489 reports
6
POLYURIA
396 reports
7
NO ADVERSE EVENT
387 reports
8
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS
383 reports
9
FATIGUE
363 reports
10
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION
347 reports